Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment

Cell Stem Cell - United States
doi 10.1016/j.stem.2017.09.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Societal Opportunities and Challenges of Genome Editing

Genome Biology
2015English

Microhomology-Assisted Scarless Genome Editing in Human iPSCs

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Genome Editing: The Road of CRISPR/Cas9 From Bench to Clinic

Experimental & Molecular Medicine
2016English

Editing the Human Genome: Balancing Safety and Regulation

The Lancet
Medicine
2018English

Predicting Venous Thromboembolism Risk From Exomes in the Critical Assessment of Genome Interpretation (CAGI) Challenges

Human Mutation
Genetics
2019English

Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Synthetic CRISPR RNA-Cas9–guided Genome Editing in Human Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Human Genome Editing: Ask Whether, Not How

Nature
Multidisciplinary
2019English

Risk‐Benefit Assessment of Foods

EFSA Journal
VeterinaryMicrobiologyFood ScienceAnimal ScienceParasitologyPlant ScienceZoology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy